JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

Search

ResMed Inc

Fechado

SetorSaúde

270.93 1.72

Visão Geral

Variação de preço das ações

24h

Atual

Mín

269.5

Máximo

271.87

Indicadores-chave

By Trading Economics

Rendimento

44M

393M

Vendas

87M

1.4B

P/E

Médio do Setor

25.197

84.243

Rendimento de Dividendos

0.87

Margem de lucro

27.593

Funcionários

10,600

EBITDA

63M

566M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+10.68% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.87%

2.28%

Próximos Ganhos

22 de abr. de 2026

Próxima data de dividendos

19 de mar. de 2026

Próxima data de ex-dividendo

12 de fev. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-107M

37B

Abertura anterior

269.21

Fecho anterior

270.93

Sentimento de Notícias

By Acuity

65%

35%

327 / 352 Ranking em Healthcare

ResMed Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

8 de fev. de 2026, 23:57 UTC

Conversa de Mercado

Uranium Outlook Heats Up on Rising Demand, Uncertain Supply -- Market Talk

8 de fev. de 2026, 23:47 UTC

Conversa de Mercado

Gold Rises Amid Growing U.S.-Iran Tensions -- Market Talk

8 de fev. de 2026, 23:43 UTC

Conversa de Mercado

Nikkei Likely to Rise Sharply After Takaichi's Election Win -- Market Talk

8 de fev. de 2026, 23:34 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

8 de fev. de 2026, 23:34 UTC

Conversa de Mercado

Landslide Election Victory of Japan's LDP Positive for Risk Assets -- Market Talk

8 de fev. de 2026, 23:26 UTC

Conversa de Mercado

Yen Skittish; Nikkei Jumps On LDP Landslide -- Market Talk

8 de fev. de 2026, 22:55 UTC

Ganhos

DBS Group 4Q Net S$2.36B Vs. Net S$2.62B >D05.SG

8 de fev. de 2026, 22:55 UTC

Ganhos

DBS Group 4Q Net Interest Income S$3.59B Vs. S$3.83B>D05.SG

8 de fev. de 2026, 22:55 UTC

Ganhos

DBS Board Proposes 4Q Dividend of 66 Singapore Cents/share>D05.SG

8 de fev. de 2026, 22:55 UTC

Ganhos

DBS Group: 2025 Total Dividend at S$3.06/share >D05.SG

8 de fev. de 2026, 22:55 UTC

Ganhos

DBS Group 4Q Net Weighed by Higher Tax Expense, Absence of Non-Recurring Gains Recrorded Last Year >D05.SG

8 de fev. de 2026, 22:55 UTC

Ganhos

DBS Group 4Q Total Income S$5.33B Vs. S$5.51B>D05.SG

8 de fev. de 2026, 21:43 UTC

Conversa de Mercado

FX Intervention Watch Resumes After Japan Election Result -- Market Talk

8 de fev. de 2026, 21:16 UTC

Conversa de Mercado

Right Of Australian Politics Reshaped as One Nation Surges -- Market Talk

8 de fev. de 2026, 21:15 UTC

Conversa de Mercado

Japan's Election Outcome to Revive Takaichi Trade -- Market Talk

7 de fev. de 2026, 09:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

7 de fev. de 2026, 09:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

7 de fev. de 2026, 05:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

7 de fev. de 2026, 02:46 UTC

Aquisições, Fusões, Aquisições de Empresas

Big Money, High Anxiety -- Barrons.com

6 de fev. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

6 de fev. de 2026, 21:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

6 de fev. de 2026, 21:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Verizon Insiders Rarely Sell Company Stock. This Insider Just Did. -- Barrons.com

6 de fev. de 2026, 21:22 UTC

Conversa de Mercado

Mexico's Inflation Seen Accelerating in January -- Market Talk

6 de fev. de 2026, 21:17 UTC

Ganhos

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

6 de fev. de 2026, 21:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

6 de fev. de 2026, 21:14 UTC

Aquisições, Fusões, Aquisições de Empresas

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- Update

6 de fev. de 2026, 21:13 UTC

Ganhos

How the Software Panic Hit BDC Stocks -- and Why Some Might Be Worth Buying -- Barrons.com

6 de fev. de 2026, 21:13 UTC

Ganhos

Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers -- Barrons.com

6 de fev. de 2026, 21:04 UTC

Conversa de Mercado

Gold Closes Out Volatile Week on Higher Note -- Market Talk

6 de fev. de 2026, 20:34 UTC

Ganhos

Tech Had an Awful Earnings Season. Other Stocks Are Saving the Day. -- Barrons.com

Comparação entre Pares

Variação de preço

ResMed Inc Previsão

Preço-alvo

By TipRanks

10.68% parte superior

Previsão para 12 meses

Média 300.64 USD  10.68%

Máximo 345 USD

Mínimo 265 USD

Com base em 13 analistas de Wall Street que oferecem metas de preço de 12 meses para ResMed Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

13 ratings

8

Comprar

5

Manter

0

Vender

Sentimento

By Acuity

327 / 352 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Baixa

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat